Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Reports
2021 Gene Therapy Report
2021 Biologics Report
2021 Sterile Drug Products Report
2021 API Market Report
2020 OSD Market Report
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
COVID-19
220 Articles Available
1
10
Can't find what you're looking for? Try our
advanced search
.
COVID-19
Lilly Modified COVID-19 Purchase Agreement for Bamlanivimab and Etesevimab Together
PR-M04-21-010
Vaccine
Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
PR-M04-21-006
Clinical Trials
Lilly, Vir Biotechnology and GSK Announce Positive Topline Data From the Phase 2 Blaze-4 Trial Evaluating Bamlanivimab With Vir-7831 in Low-risk Adults With Covid-19
PR-M04-21-004
Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses of CureVac’s COVID-19 Vaccine Candidate, CVnCoV
PR-M03-21-006
Endpoints
NeuroRx Announces ZYESAMI™ Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19
PR-M03-21-005
COVID-19 Impacts
Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?
PAO-03-21-NI-01
COVID-19 Therapeutics
Tevogen Bio Announces Partnership With BioCentriq to Enhance Tevogen’s Development Capacity of Its Proprietary Targeted T Cell Therapy For COVID-19
PR-M03-21-002
COVID-19 Vaccine
UBC Announces Initiative to Accelerate COVID-19 Vaccine Real-World Evidence Generation
PR-M11-20-046
COVID-19 Vaccine
HALIX Signs Agreement With AstraZeneca For Commercial Manufacture Of COVID-19 Vaccine
PR-M11-20-031
Cover Story
Facing the Challenges of the COVID-19 Pandemic: Rentschler Biopharma
PAP-Q4-20-CL-028
Nice Insight Overview
Delivering Vaccines During a Pandemic
PAP-Q4-20-NI-001
COVID-19 vaccine
How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Partnerships
PAP-Q4-20-CL-007
Virtual Trade Shows
Meeting the Challenges of the Pandemic through Virtual Trade Shows
PAP-Q4-20-CL-011
Small Molecule
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
PAP-Q4-20-CL-025
Digital Marketing
Creating Quality Content for Effective Digital Marketing
PAP-Q4-20-CL-024
COVID-19 Vaccine Distribution
Preparing for COVID-19 Vaccine Distribution Despite Tight Shipping Capacity
PAP-Q4-20-CL-006
Mobile Research Nursing
Mobile Research Nursing: Evolving to Meet Pandemic Challenges
PAP-Q4-20-CL-013
COVID-19 Therapeutics
How an Agile Company Addressed the Pandemic: Moving from Psychiatric Medicines to a COVID-19 Therapeutic
PAP-Q4-20-CL-017
Supply Chain
Nationalism and the Pharmaceutical Supply Chain
PAP-Q4-20-CL-012
There Were No Passengers On This Journey
The Future of Healthcare
How Does Inceptor Bio Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-002
The Future of Healthcare
How Does Pii Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-012
The Future of Healthcare
How Does Avara Pharmaceutical Services Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-011
The Future of Healthcare
How Does Dynamk Capital Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-013
1
10
»
